about
Guiding principles and checklist for population-based quality metrics.Depressive affect and hospitalization risk in incident hemodialysis patients.Anaphylaxis and hypotension after administration of peginesatideAdherence barriers to chronic dialysis in the United StatesThe evolving role of the medical director of a dialysis facilityDabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplastyNutritional Competence and Resilience among Hemodialysis Patients in the Setting of Dialysis Initiation and HospitalizationIntensity of care and better outcomes among hemodialysis patients: a role for the Medical Director.PD First: peritoneal dialysis as the default transition to dialysis therapy.Toward population management in an integrated care model.Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers.The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.Nephrologists and Integrated Kidney Disease Care: Roles and Skills Essential for Nephrologists for Future Success.A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes.Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.Doing More Than Caring About Quality.Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).To cool, or too cool: Is reducing dialysate temperature the optimal approach to preventing intradialytic hypotension?Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States.Lessons learned from the inside. A physician who started an entrepreneurial IT business shares his experiences in staving off disaster.No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease.Toward population management in an integrated care model.Hemodialysis catheter care strategies: a cluster-randomized quality improvement initiative.Hemoglobin level and transfusions in patients on maintenance dialysis: where the rubber meets the road.High Hemoglobin A1c levels and glycemic variability increase risk of severe hypoglycemia in diabetic hemodialysis patients.Electronic communication and text messaging among nephrology providers.Right TraC™ Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients.Dynamics of Nutritional Competence in the Last Year Before Death in a Large Cohort of US Hemodialysis Patients.Depressive affect in incident hemodialysis patients.Integrating kidney transplantation into value-based care for people with renal failure.First-year outcomes of incident peritoneal dialysis patients in the United States.Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome.Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.Quality of Life in Dialysis Patients: A Retrospective Cohort Study.Improving outcomes of dialysis patients by population health management-the Global Chief Medical Officer Initiative.Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986.Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population
P50
Q33715845-D77DB2A2-F68B-4B79-9E6E-228D6CA09505Q34292832-86EFE279-3909-4DE9-ACA3-C6DF4FE05E5FQ34357203-4A1E026E-A0D7-4897-A141-FADEC66C9A46Q34427672-3247FC93-E8BA-4138-B76D-2165406CE715Q35051198-D1B403F5-58EF-4AF6-AEAB-A092A49D7DADQ35187005-EB0C3182-F341-4895-B87D-4BE27BA659DEQ35985911-5AB6D2C1-1349-444F-BEF3-0C9E2E8F2B01Q36025639-C4E3CAED-390D-4D50-8CC8-30F65FD834E9Q38011231-2102628A-165B-43DE-9CCB-FE6115976C3FQ38150449-95130D98-2182-4D1A-9DFE-EFE727CA3B51Q38185250-ECDA6CB2-901F-4098-9CBD-962C480F718AQ38243210-26339B56-A6B6-415C-8E0E-7E34DEDEB54DQ38603433-95872684-D31C-459D-99A9-19C30105A517Q38729355-0F3BD14A-974F-4E2D-B0E3-7C135F48EC05Q38801820-B7059E42-8556-4F01-8218-1DACC6F696D0Q38804703-AAD542B3-1947-4609-9B1A-E31CAC2A9B10Q38867295-0A5F6346-9365-4120-A4C2-32A1E7FF55C0Q38910579-FC2DFF42-76DA-4E74-B353-AE68FC2DF2A4Q39170694-5C92F7B5-14CB-4A42-A88E-A2C3CEBB80B3Q39407364-DD9F266F-E7DE-4951-8174-FDBA65CC0D83Q40908156-14C9B261-BC1B-453E-8CCC-8063969A3BBDQ42035012-15B68A78-15AA-44C8-B5F3-6C3A31E59647Q43879938-0D2D844D-64B9-44C1-8EED-DA0C577875F1Q44018188-6A611FCD-5B31-4C5A-B28D-BDBF6E1735F5Q44213809-F779B618-316C-4F7A-9F01-69A41323683BQ44328415-33611885-C6EE-42AE-A200-CA27F76B442AQ44534951-7349C5D4-A5F1-4C0B-835A-48879D775A9BQ45904446-F76B1F80-BA56-4753-89A6-3BCFB4F3CCC0Q46039627-AECA84E5-4566-44C9-BFEE-177DE56716F3Q46428227-8865B619-B9B8-4205-8006-FB08AEAA45BAQ47752352-9BEDF284-FAAC-4B63-A5CB-81F1CDD742C7Q49279915-0720E935-AE6B-4442-BDF3-206BCBBAD8A4Q50132034-97CFA452-9D16-4735-876E-EB3CDB48EB53Q51134416-0A0CC860-6A86-46FB-B688-365AE925FB36Q51165588-6E88E4D9-3515-4CEC-A5A6-F699AE39E263Q52639981-3905B294-AFBD-4CBC-AF27-0A3E807E3641Q53477838-2D51D1C3-04BF-44DA-AE05-0160A583E506Q53747695-17F2FD76-96B4-485F-AD60-0157EB2DA7BFQ53858341-315A192C-52C7-4FEA-AC8A-DCFDA1DA5EAAQ62618689-68BA2FDA-89C1-4824-8925-2220AD81018F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Franklin Maddux
@ast
Franklin Maddux
@en
Franklin Maddux
@es
Franklin Maddux
@nl
Franklin Maddux
@sl
type
label
Franklin Maddux
@ast
Franklin Maddux
@en
Franklin Maddux
@es
Franklin Maddux
@nl
Franklin Maddux
@sl
prefLabel
Franklin Maddux
@ast
Franklin Maddux
@en
Franklin Maddux
@es
Franklin Maddux
@nl
Franklin Maddux
@sl
P106
P31
P496
0000-0003-1395-2011